TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
HURA

TuHURA Biosciences Inc

Healthcare · Biotechnology

2.10$ +0.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

TuHURA Biosciences Inc (HURA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Total Assets" came in at 27 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet HURA
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
2.6 6.4 7.9 7.1 4.0 2.9 14 6.4 15 4.4 20 27
2.0 6.3 7.9 7.0 4.0 2.8 12 5.7 15 4.2 20 4.6
1.8 6.2 6.6 6.0 3.7 2.4 11 5.5 14 3.7 13 3.6
1.8 6.2 6.6 6.0 3.7 2.4 11 5.5 14 3.7 13 3.6
0.0 0.0 0.1 0.0 0.0 – – – 0.1 0.3 0.2 –
– – – – – – – – – – 0.2 –
– – – – – – – – – – 0.0 11
– 0.0 0.0 0.0 0.0 – – – – – – 11
3.4 1.5 1.3 1.6 2.1 2.7 3.0 7.2 2.9 5.9 5.4 6.4
0.9 0.6 1.3 1.6 2.1 2.7 2.8 7.2 2.9 3.6 5.3 5.9
– – – – – – – 0.6 0.1 0.0 0.2 0.4
– 0.6 1.3 1.5 1.7 2.0 2.2 0.4 1.9 1.9 3.2 3.8
– – – – – – – – – 2.3 – –
-0.8 4.9 6.6 5.4 2.0 0.3 11 -0.7 12 -1.6 15 21
-19 -32 -41 -52 -61 -70 -111 -49 -59 -88 -111 -141
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 19 48

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?